PMID- 28673351 OWN - NLM STAT- MEDLINE DCOM- 20180416 LR - 20181113 IS - 1465-993X (Electronic) IS - 1465-9921 (Print) IS - 1465-9921 (Linking) VI - 18 IP - 1 DP - 2017 Jul 3 TI - Is it possible to claim or refute sputum eosinophils >/= 3% in asthmatics with sufficient accuracy using biomarkers? PG - 133 LID - 10.1186/s12931-017-0615-9 [doi] LID - 133 AB - The concept of asthma inflammatory phenotypes has proved to be important in predicting response to inhaled corticosteroids. Induced sputum, which has been pivotal in the development of the concept of inflammatory phenotypes, is however not widely available. Several studies have proposed to use surrogate exhaled or blood biomarkers, like fractional exhaled nitric oxide (FENO), blood eosinophils and total serum immunoglobulin E (IgE). However, taken alone, each of these biomarkers has moderate accuracy to identify sputum eosinophilia. Here, we propose a new approach based on the likelihood ratio to study which thresholds of these biomarkers, taken alone or in combination, were able to rule in or rule out sputum eosinophils >/=3%. We showed in a large population of 869 asthmatics that combining FENO, blood eosinophils and total serum IgE could accurately predict sputum eosinophils >/= or <3% in 58% of our population. FAU - Demarche, Sophie F AU - Demarche SF AUID- ORCID: 0000-0002-5628-0262 AD - Department of Respiratory Medicine, CHU Liege, GIGA I3 Research Group, University of Liege, Liege, Belgium. Sophie.Demarche@ulg.ac.be. AD - Department of Clinical Pharmacy, Center for Interdisciplinary Research on Medicines, University of Liege, Liege, Belgium. Sophie.Demarche@ulg.ac.be. FAU - Schleich, Florence N AU - Schleich FN AD - Department of Respiratory Medicine, CHU Liege, GIGA I3 Research Group, University of Liege, Liege, Belgium. FAU - Paulus, Virginie A AU - Paulus VA AD - Department of Respiratory Medicine, CHU Liege, GIGA I3 Research Group, University of Liege, Liege, Belgium. FAU - Henket, Monique A AU - Henket MA AD - Department of Respiratory Medicine, CHU Liege, GIGA I3 Research Group, University of Liege, Liege, Belgium. FAU - Van Hees, Thierry J AU - Van Hees TJ AD - Department of Clinical Pharmacy, Center for Interdisciplinary Research on Medicines, University of Liege, Liege, Belgium. FAU - Louis, Renaud E AU - Louis RE AD - Department of Respiratory Medicine, CHU Liege, GIGA I3 Research Group, University of Liege, Liege, Belgium. LA - eng PT - Letter PT - Research Support, Non-U.S. Gov't DEP - 20170703 PL - England TA - Respir Res JT - Respiratory research JID - 101090633 RN - 0 (Biomarkers) SB - IM MH - Adult MH - Asthma/blood/*diagnosis/*metabolism MH - Biomarkers/blood/metabolism MH - Cross-Sectional Studies MH - Eosinophils/*metabolism MH - Female MH - Humans MH - Male MH - Middle Aged MH - Retrospective Studies MH - Sputum/*metabolism PMC - PMC5496313 OTO - NOTNLM OT - Asthma OT - Biomarkers OT - Blood OT - Eosinophils OT - Immunoglobulin E OT - Nitric oxide OT - Phenotype OT - Sputum COIS- ETHICS APPROVAL AND CONSENT TO PARTICIPATE: The study was approved by the ethics committee of the University Hospital of Liege (Ref 2016/276). CONSENT FOR PUBLICATION: Not applicable. COMPETING INTERESTS: SD, FS, VP, MH: no competing interests. TVH: grants from Amgen, outside the submitted work. RL: grants and personal fees from GSK, Chiesi, Astra Zeneca, Novartis, outside the submitted work. PUBLISHER'S NOTE: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. EDAT- 2017/07/05 06:00 MHDA- 2018/04/17 06:00 PMCR- 2017/07/03 CRDT- 2017/07/05 06:00 PHST- 2017/05/04 00:00 [received] PHST- 2017/06/25 00:00 [accepted] PHST- 2017/07/05 06:00 [entrez] PHST- 2017/07/05 06:00 [pubmed] PHST- 2018/04/17 06:00 [medline] PHST- 2017/07/03 00:00 [pmc-release] AID - 10.1186/s12931-017-0615-9 [pii] AID - 615 [pii] AID - 10.1186/s12931-017-0615-9 [doi] PST - epublish SO - Respir Res. 2017 Jul 3;18(1):133. doi: 10.1186/s12931-017-0615-9.